Insiders who reported open-market trades in the last 12 months at the companies SUVRETTA CAPITAL MANAGEMENT, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John W. Childs - $20.71M in MANE purchases and sales in the last 12 months
Patrick G. Enright - $18.27M in MANE purchases and sales in the last 12 months
SUVRETTA CAPITAL MANAGEMENT, LLC is an investment firm, tracked as Director of Veradermics, Inc (MANE). InsiderAlpha holds 9 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has SUVRETTA CAPITAL MANAGEMENT, LLC submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has SUVRETTA CAPITAL MANAGEMENT, LLC been buying or selling stock?
Recorded transactions: 43 open-market purchases ($34.33M) and 2 open-market sales ($80.44M) across all tracked filings.
SUVRETTA CAPITAL MANAGEMENT, LLC is Director of Veradermics, Inc (MANE). 9 SEC Form 4 filings on record going back to 2024, most recently on 21 August 2026. Most recent open-market trade: sold $6.37M of MANE on 21 August 2026. Lifetime open-market purchases: $34.33M. Lifetime open-market sales: $80.44M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by SUVRETTA CAPITAL MANAGEMENT, LLC.
InsiderAlpha's records for SUVRETTA CAPITAL MANAGEMENT, LLC go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $798K (43 buys totaling $34.33M). The largest single buy on record is $10.14M of BNTC in 2025. Sales side: 2 recorded sales totaling $80.44M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
